Aplasa study update: Primary thrombosis prevention in asymptomatic aPL(+) patients with aspirin (ASA)

被引：0
|
作者：
Erkan, D
Sammaritano, L
Levy, R
Harrison, MJ
Peterson, M
Yazici, Y
Lockshin, MD
机构：
[1] Hosp Special Surg, New York, NY USA
[2] Univ Fed Rio de Janeiro, Hosp Pedro Ernesto, Rio De Janeiro, Brazil
[3] Long Isl Coll Hosp, Brooklyn, NY USA
来源：
THROMBOSIS RESEARCH | 2004年 / 114卷 / 5-6期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：618 / 619
页数：2
相关论文
共 50 条
  • [41] Do Clinicians Recommend Aspirin to Patients for Primary Prevention of Cardiovascular Disease?
    Fiscella, Kevin
    Winters, Paul C.
    Mendoza, Michael
    Noronha, Gary J.
    Swanger, Carlos M.
    Bisognano, John D.
    Fortuna, Robert J.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2015, 30 (02) : 155 - 160
  • [42] Preventing Cardiovascular Disease in Patients with Diabetes: Use of Aspirin for Primary Prevention
    Desai, Dhaval
    Ahmed, Haitham M.
    Michos, Erin D.
    CURRENT CARDIOLOGY REPORTS, 2015, 17 (03) : 1 - 9
  • [43] Aspirin in Primary Prevention of Myocardial Infarction/Angina and Stroke in Hypertensive Patients
    Almas, Aysha
    Ghazni, Muhammad Salman
    Hashmani, Shahrukh
    Mushtaq, Zain
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2018, 28 (07): : 574 - 574
  • [44] Patient-level analysis of five international cohorts further confirms the efficacy of aspirin for the primary prevention of thrombosis in patients with antiphospholipid antibodies
    Arnaud, Laurent
    Mathian, Alexis
    Devilliers, Herve
    Ruffatti, Amelia
    Tektonidou, Maria
    Forastiero, Ricardo
    Pengo, Vittorio
    Lambert, Marc
    Lefevre, Guillaume
    Martinez-Zamora, Maria Angeles
    Balasch, Juan
    Wahl, Denis
    Amoura, Zahir
    AUTOIMMUNITY REVIEWS, 2015, 14 (03) : 192 - 200
  • [45] PREVENTION OF RECURRENT VASCULAR ACCESS THROMBOSIS IN HEMODIALYSIS-PATIENTS - A PILOT-STUDY USING ASPIRIN PLUS SULFINPYRAZONE
    DOMOTO, DT
    BAUMAN, JE
    JOIST, JH
    HAEMOSTASIS, 1986, 16 : 66 - 66
  • [46] Aspirin for Primary Prevention of Cardiovascular Events in Patients With Elevated Lipoprotein(a): The Multi-Ethnic Study of Atherosclerosis
    Bhatia, Harpreet S.
    Trainor, Patrick
    Carlisle, Samantha
    Tsai, Michael Y.
    Criqui, Michael H.
    Defilippis, Andrew P.
    Tsimikas, Sotirios
    CIRCULATION, 2022, 146
  • [47] Study of apparent aspirin resistance in 100 consecutive patients with type 2 diabetes in primary cardiovascular prevention
    Decaudain, A.
    Legal, S.
    Baralon, C.
    Lamrache, N.
    Charriere, S.
    Groisne, L.
    Hanss, M.
    Moulsma, M.
    Moulin, P.
    DIABETOLOGIA, 2010, 53
  • [48] THE PHYSICIANS HEALTH STUDY - ASPIRIN FOR THE PRIMARY PREVENTION OF MYOCARDIAL-INFARCTION
    SHAPIRO, S
    NEW ENGLAND JOURNAL OF MEDICINE, 1988, 318 (14): : 924 - 924
  • [49] Aspirin for Stroke Prevention in Elderly Patients With Vascular Risk Factors Japanese Primary Prevention Project
    Uchiyama, Shinichiro
    Ishizuka, Naoki
    Shimada, Kazuyuki
    Teramoto, Tamio
    Yamazaki, Tsutomu
    Oikawa, Shinichi
    Sugawara, Masahiro
    Ando, Katsuyuki
    Murata, Mitsuru
    Yokoyama, Kenji
    Minematsu, Kazuo
    Matsumoto, Masayasu
    Ikeda, Yasuo
    STROKE, 2016, 47 (06) : 1605 - U468
  • [50] Health Benefits and Cost-Effectiveness of Asymptomatic Screening for Hypertension and High Cholesterol and Aspirin Counseling for Primary Prevention
    Dehmer, Steven P.
    Maciosek, Michael V.
    LaFrance, Amy B.
    Flottemesch, Thomas J.
    ANNALS OF FAMILY MEDICINE, 2017, 15 (01) : 23 - 36
12345